Evaluation of the Impact of the UPLUG Device Onto the Infection Rate of Indwelling Central Venous Catheters in Patients Undergoing Chronic Hemodialysis (UPLUG-EVIDENCE)
Renal Disease, Chronic, Hemodialysis Catheter Infection
About this trial
This is an interventional treatment trial for Renal Disease, Chronic focused on measuring Central venous catheter, UPLUG, Infection
Eligibility Criteria
Inclusion Criteria: End-stage renal disease Chronic haemodialysis indwelling de novo or replacement central veinous catheter Exclusion Criteria: Life expectancy < 1 year Renal transplantation already scheduled at inclusion (living donor) Current infection of CVC percutaneous or subcutaneous site Pregnant or breastfeeding female, or women without a medically significant contraceptive regimen Patient with mechanical heart valve Patient with an AVF likely to be functional within 1 month Strictly more than 3 dialysis sessions a week Patient undergoing haemodialysis session > 4h30 Participation to another clinical study in the last 30 days period Patient unable to give a freely-given, written, informed consent Vulnerable participants
Sites / Locations
- Hôpital Tenon, service de NéphrologieRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
UPLUG Arm
Standard Of Care Arm
Patients will have regular central veinous catheter and UPLUG device for their dialysis sessions.
Patients will have regular central veinous catheter (standard of care) for their dialysis.